EN BM
Cellise Therapeutics Ask on WhatsApp

Case studies

CRT in practice: eight patient cases.

Each case sets out the patient’s condition, which CRT formulations were given and when, and the laboratory results recorded along the way. Open a case to read the full summary with its treatment records and lab tables.

Patient details are anonymised. CRT was given alongside each patient’s existing care, and individual results vary.

  1. Case 01

    Chronic kidney disease

    Female, 74

    Kidney function improved and has remained stable.

    Started
    REDOX+ Aug 2020; LUMINA and LIPON added in 2021
    Now
    Monthly maintenance with all three
    View PDF Download PDF, 5 pages, 0.9 MB

  2. Case 02

    Chronic kidney disease

    Female, 64

    Kidney function improved and has remained stable.

    Started
    REDOX+ Feb 2020
    Now
    Ongoing REDOX+
    View PDF Download PDF, 5 pages, 0.7 MB

  3. Case 03

    Chronic kidney disease

    Female, 72

    Renal function improved, then stabilised, with no documented deterioration.

    Started
    REDOX+ Oct 2021; LUMINA added during the course
    Now
    Ongoing treatment
    View PDF Download PDF, 5 pages, 0.8 MB

  4. Case 04

    Post-stroke, with ischaemic heart disease and CKD

    Male, 60, post-CABG

    Recovered from the post-stroke condition after one full CRT cycle; kidney function improved and maintained.

    Started
    REDOX+, LUMINA and LIPON from Jun 2021
    Now
    Monthly REDOX+ and LIPON maintenance
    View PDF Download PDF, 5 pages, 0.9 MB

  5. Case 05

    Psoriasis

    Female, 25

    Lesion on the right forearm resolved, with no recurrence since 2021.

    Course
    One cycle of REDOX+ from Jan 2021
    Now
    No maintenance needed
    View PDF Download PDF, 2 pages, 1.0 MB

  6. Case 06

    Stage 5 CKD with psoriasis

    Male, 34

    eGFR rose from 15.0 to 22.0; the psoriatic lesion thinned markedly, with no cracking.

    Course
    All three formulations, Jun to Aug 2022
    View PDF Download PDF, 3 pages, 1.6 MB

  7. Case 07

    Pan-colonic diverticular disease with raised tumour markers

    Male, 67

    Tumour markers returned to within reference range; follow-up PET scan in Feb 2023.

    Course
    REDOX+ and LIPON, Nov 2022 to Feb 2023
    View PDF Download PDF, 2 pages, 0.2 MB

  8. Case 08

    Raised CA19-9 tumour marker

    Female, 67

    CA19-9 has stayed within the normal range since December 2022.

    Started
    REDOX+ May 2022; all three from Dec 2022
    Now
    Monthly maintenance with all three
    View PDF Download PDF, 3 pages, 0.5 MB

Wondering whether CRT could help in a similar case?

Ask us →
Ask on WhatsApp